HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.108.058347v1 50/5/688    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hamami, M. E. Articles by Antoch, G. Search for Related Content PubMed PubMed Citation Articles by Hamami, M. E. Articles by Antoch, G.

SPECT/CT with ^99mTc-MAA in Radioembolization with ⁹⁰Y Microspheres in Patients with Hepatocellular Cancer

¹ Department of Nuclear Medicine, University Hospital Essen, University at Duisburg-Essen, Essen, Germany; ² Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University at Duisburg-Essen, Essen, Germany; and ³ Department of Gastroenterology and Hepatology, University Hospital Essen, University at Duisburg-Essen, Essen, Germany

Correspondence: For correspondence or reprints contact: Monia Estella Hamami, Department of Nuclear Medicine, University Hospital of Essen, Hufelandstrasse 55, 45122, Essen, Germany. E-mail: Monia.Hamami{at}uk-essen.de

Radioembolization with ⁹⁰Y microspheres is a novel treatment for hepatic tumors. Generally, hepatic arteriography and ^99mTc-macroaggregated albumin (MAA) scanning are performed before selective internal radiation therapy to detect extrahepatic shunting to the lung or the gastrointestinal tract. Whereas previous studies have used only planar or SPECT scans, the present study used ^99mTc-MAA SPECT/CT scintigraphy (SPECT with integrated low-dose CT) to evaluate whether SPECT/CT and additional diagnostic contrast-enhanced CT before radioembolization with ⁹⁰Y microspheres are superior to SPECT or planar imaging alone for detection of gastrointestinal shunting. Methods: In a prospective study, we enrolled 58 patients (mean age, 66 y; SD, 12 y; 10 women and 48 men) with hepatocellular carcinoma who underwent hepatic arteriography and scintigraphy with ^99mTc-MAA using planar imaging, SPECT, and SPECT with integrated low-dose CT of the upper abdomen (acquired with a hybrid SPECT/CT camera). The ability of the different imaging modalities to detect extrahepatic MAA shunting was compared. Patient follow-up of a mean of 180 d served as the standard of reference. Results: Gastrointestinal shunting was revealed by planar imaging in 4, by SPECT in 9, and by SPECT/CT in 16 of the 68 examinations. For planar imaging, the sensitivity for detection of gastrointestinal shunting was 25%, the specificity 87%, and the accuracy 72%. For SPECT without CT, the sensitivity was 56%, the specificity 87%, and the accuracy 79%. SPECT with CT fusion had a sensitivity of 100%, a specificity of 94%, and an accuracy of 96%. In 3 patients, MAA deposits in the portal vein could accurately be attributed to tumor thrombus only with additional information from contrast-enhanced CT. The follow-up did not show any gastrointestinal complications. Conclusion: SPECT with integrated low-dose CT using ^99mTc-MAA is beneficial in radioembolization with ⁹⁰Y microspheres because it increases the sensitivity and specificity of ^99mTc-MAA SPECT when detecting extrahepatic arterial shunting. The overall low risk of gastrointestinal complications in radioembolization may therefore be further reduced by SPECT/CT.

Key Words: hepatocellular carcinoma • SPECT/CT • radioembolization • ⁹⁰Y • microspheres

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2009 50: 11A-12A. [Full Text]